- Next Science Ltd Ordinary Shareholders Meeting TranscriptOct 24, 2023
- Half Year 2023 Next Science Ltd Earnings Call TranscriptAug 31, 2023$0.4222Earnings
- Full Year 2022 Next Science Ltd Earnings Call TranscriptFeb 28, 2023$0.49Earnings
- Next Science Ltd Corporate Presentation TranscriptOct 27, 2022
- Half Year 2022 Next Science Ltd Earnings Call TranscriptAug 25, 2022$0.6376Earnings
- Next Science Ltd Annual Shareholders Meeting TranscriptMay 27, 2022
- Full Year 2021 Next Science Ltd Earnings Call TranscriptFeb 27, 2022Earnings
- Half Year 2021 Next Science Ltd Earnings Call TranscriptAug 30, 2021$1.05 (-0.94%)Earnings
- Next Science Ltd Annual Shareholders Meeting TranscriptMay 05, 2021
- Full Year 2020 Next Science Ltd Earnings Call TranscriptFeb 23, 2021$1.07Earnings
- Next Science Ltd Annual Shareholders Meeting TranscriptNov 17, 2020
- Half Year 2020 Next Science Ltd Earnings Call TranscriptAug 26, 2020$1 (-4.76%)Earnings
- Next Science Ltd Annual Shareholders Meeting TranscriptMay 06, 2020
- Full Year 2019 Next Science Ltd Earnings Call TranscriptFeb 28, 2020$1.22Earnings
Half Year 2022 Next Science Ltd Earnings Call Transcript
Thank you for standing by, and welcome to the Next Science Limited 2022 Half Year Results Conference Call. (Operator Instructions)
And now I would like to hand the conference over to Ms. Judith Mitchell, Managing Director. Please go ahead.
Good morning, ladies and gentlemen, and thank you for joining the first half call for Next Science for the financial year of 2022. For those people who are not familiar with Next Science, we're a company that have a novel laser for the problems caused by biofilms and their ability to accelerate the issues that cause chronic infection. Our mission as a company is to use our XBIO technology platform to help resolve these issues and provide products to physicians to assist in healing people and saving lives.
Business is very pleased to report that for the first half of 2022, we delivered our strongest revenue to date for a first half, being USD 5.4 million. This result is 38% up on the prior first half of 2021 with product sales up 67%.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)